LINE-1 ORF1p Mimics Viral Innate Immune Evasion Mechanisms in Pancreatic Ductal Adenocarcinoma

Eunae You1,2, Bidish K Patel1, Alexandra S Rojas1

  • 1Mass General Cancer Center, Harvard Medical School, Charlestown, Massachusetts.

Cancer Discovery
|February 7, 2025
PubMed
Abstract

Insights

Pancreatic ductal adenocarcinoma (PDAC) uses ORF1p protein to suppress antiviral immunity. Inhibiting ORF1p activates immune responses, slows tumor growth, and may offer a new therapeutic strategy for PDAC.

Area of Science:

  • Immunology
  • Oncology
  • Molecular Biology

Background:

  • Pancreatic ductal adenocarcinoma (PDAC) often evades immune surveillance.
  • Viral-repeat RNA elements can trigger immune responses within tumors.
  • Long interspersed nuclear element 1 (LINE-1) open reading frame 1 protein (ORF1p) is implicated in cancer progression.

Purpose of the Study:

  • To investigate the role of LINE-1 ORF1p in suppressing antiviral immune responses in PDAC.
  • To determine if targeting ORF1p can modulate anti-tumor immunity and PDAC progression.

Main Methods:

  • Analysis of ORF1p expression in PDAC tissues.
  • In vitro and in vivo experiments to assess the impact of ORF1p suppression on immune cell activity.
  • Evaluation of tumor growth and epithelial-mesenchymal transition (EMT) markers following ORF1p inhibition.

Main Results:

  • PDAC utilizes ORF1p to specifically dampen immune responses against viral-repeat RNA.
  • Suppression of ORF1p expression reactivates anti-viral immune signaling pathways.
  • Reduced ORF1p levels led to decreased tumor growth and inhibited EMT.
  • High ORF1p expression is correlated with poorer patient prognosis.

Conclusions:

  • LINE-1 ORF1p is a key mechanism for immune evasion in PDAC.
  • Targeting ORF1p represents a promising therapeutic strategy to enhance anti-tumor immunity in PDAC.
  • Further research into ORF1p inhibitors could lead to novel PDAC treatments.

Related Concept Videos

Cancer Cell Migration through Invadopodia01:35

Cancer Cell Migration through Invadopodia

Invadosome is a broad category of cell surface structures with proteolytic activity that  degrades the extracellular matrix (ECM). Invadosomes are present in normal cell types, including macrophages, endothelial cells, and neurons, as well as tumor cells. Although the macrophage podosomes and tumor cell invadopodia are classified as invadosomes, they have different structures, molecular pathways, and functions. Podosomes are short structures that last for a few minutes. However,...
2.3K
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
4.4K
Immune Response Against Viral Pathogens01:29

Immune Response Against Viral Pathogens

The immune system's response to viral infections is a complex and coordinated process involving natural killer (NK) cells, T cell-mediated responses, and antibody-mediated responses.
NK Cells
NK cells are a crucial part of our innate immune system, acting as the first line of defense against viral infections. These cells can recognize and kill infected cells without prior exposure to the virus, effectively slowing down the spread of infection. Additionally, NK cells produce proinflammatory...
731